Braizon Therapeutics
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $8.6M
Investors
- 3
About Braizon Therapeutics
Braizon Therapeutics, Inc.Braizon Therapeutics was founded in 2015 in Tokyo, Japan. The company develops advanced drug delivery systems aimed at treating central nervous system disorders. Mariko Tosu is the founder, while Philip Davy serves as the CEO.14 million.Braizon Therapeutics specializes in innovative drug delivery systems aimed at addressing central nervous system (CNS) disorders through its proprietary technology that enables effective transport of therapeutic agents across the blood-brain barrier (BBB). The core product offerings include a Drug Delivery System Platform developed from collaborative research efforts by renowned engineering and medical professors. This platform enhances drug delivery efficiency for CNS diseases like Alzheimer's and Parkinson's, utilizing specialized nanoparticles such as micro-nanocapsules modified with ligands.Braizon Therapeutics generates revenue primarily through licensing agreements with pharmaceutical and biotechnology companies, as well as collaborations with academic institutions. These partnerships typically involve Braizon licensing its Drug Delivery System Platform to develop new therapies for specific CNS disorders, structured around upfront fees, milestone payments, and royalties based on future sales of developed drugs.In July 2021, Braizon Therapeutics Inc. The rationale for this continued investment highlights the social importance of maintaining research connections and the steady progress of their R&D activities. Future growth plans include the design and launch of new products targeting CNS disorders, with specific timelines for these developments not disclosed.
Who invested in Braizon Therapeutics
3 investors across 2 rounds
See all investors in Braizon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Braizon Therapeutics
Who invested in Braizon Therapeutics?
Braizon Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Braizon Therapeutics raised?
Braizon Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Braizon Therapeutics last raise money?
Braizon Therapeutics's most recent round on record is a Series B, in Jul 2021.
What does Braizon Therapeutics do?
Braizon Therapeutics is a biotechnology company.
Where is Braizon Therapeutics headquartered?
Braizon Therapeutics is headquartered in Tokyo, Japan.
Which VCs invest in companies like Braizon Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Braizon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Braizon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.